{"api":"v1","generated_at":"2026-09-15T19:12:20.674Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/clinicalintelpulse-theaslangroupllc-com-api-clinical-deal-signal-20105e","pinned_page":"https://tollindex.com/e/clinicalintelpulse-theaslangroupllc-com-api-clinical-deal-signal-20105e/at/2026-09-15T16-57Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-09-15T16:57:44.360Z","snapshot_stamp":"2026-09-15T16-57Z","endpoint":{"slug":"clinicalintelpulse-theaslangroupllc-com-api-clinical-deal-signal-20105e","canonical_url":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal","resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal","http_method":"GET","type":"http","x402_version":2,"registries":["cdp","binance"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.","service_name":"ClinicalIntelPulse","declared_category":null,"declared_tags":["biotech-ma","licensing","business-development","deal-signal","big-pharma"],"route_template":null,"registry_updated":"2026-08-20T14:01:57.877Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"clinical deal signal","category":"market-data","first_observed_by_toll":"2026-09-10T19:08:24.178Z","last_observed_by_toll":"2026-09-15T16:57:44.360Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"binance","at":"2026-09-10T19:08:24.178Z","event":"listed"},{"registry":"cdp","at":"2026-09-10T19:08:24.178Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.35 USDC","amount_units":0.35,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":1,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"GatewayWalletBatched","symbol":"USDC","decimals":6,"amount_display":"0.35 USDC","amount_units":0.35,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":2,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","asset_name":null,"symbol":"USDC","decimals":6,"amount_display":"0.35 USDC","amount_units":0.35,"decimals_known":true,"pay_to":"985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1","scheme":"exact"},{"registry":"cdp","ordinal":3,"network":"eip155:137","asset":"0x3c499c542cef5e3811e1192ce70d8cc03d5c3359","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.35 USDC","amount_units":0.35,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":4,"network":"eip155:42161","asset":"0xaf88d065e77c8cc2239327c5edb3a432268e5831","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.35 USDC","amount_units":0.35,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":5,"network":"eip155:480","asset":"0x79a02482a880bce3f13e09da970dc34db4cd24d1","asset_name":"USDC","symbol":null,"decimals":null,"amount_display":"350000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":6,"network":"eip155:143","asset":"0x754704bc059f8c67012fed69bc8a327a5aafb603","asset_name":"USDC","symbol":null,"decimals":null,"amount_display":"350000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":7,"network":"eip155:196","asset":"0x779ded0c9e1022225f8e0630b35a9b54be713736","asset_name":"USD₮0","symbol":null,"decimals":null,"amount_display":"350000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":8,"network":"eip155:999","asset":"0xb88339cb7199b77e23db6e890353e22632ba630f","asset_name":"USDC","symbol":null,"decimals":null,"amount_display":"350000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":9,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","asset":"31566704","asset_name":null,"symbol":null,"decimals":null,"amount_display":"350000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"62A253YPATFNJCPRKID3FKD77MYJFNTVRYRP4B4JWG36EGLPY7UXFWGI7I","scheme":"exact"},{"registry":"cdp","ordinal":10,"network":"xrpl:0","asset":"XRP","asset_name":null,"symbol":null,"decimals":null,"amount_display":"350000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","scheme":"exact"},{"registry":"cdp","ordinal":11,"network":"xrpl:0","asset":"524C555344000000000000000000000000000000","asset_name":null,"symbol":null,"decimals":null,"amount_display":"amount not declared","amount_units":null,"decimals_known":false,"pay_to":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","scheme":"exact"},{"registry":"cdp","ordinal":12,"network":"eip155:56","asset":"0x8d0d000ee44948fc98c9b98a4fa4921476f08b0d","asset_name":"World Liberty Financial USD","symbol":null,"decimals":null,"amount_display":"350000000000000000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"binance","ordinal":0,"network":"eip155:56","asset":"0x8d0d000ee44948fc98c9b98a4fa4921476f08b0d","asset_name":null,"symbol":null,"decimals":null,"amount_display":"350000000000000000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"eip3009"}],"counters":{"observed_at":"2026-09-15T16:57:44.360Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-08-20T14:01:57.673Z"},"validation":{"latest":{"observed_at":"2026-09-15T04:09:34.117Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-09-15"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-09-15T04:09:34.117Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-15","state_changed":false},{"observed_at":"2026-09-14T04:07:56.219Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-14","state_changed":false},{"observed_at":"2026-09-13T04:07:32.223Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-13","state_changed":false},{"observed_at":"2026-09-12T06:22:43.747Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-12","state_changed":false},{"observed_at":"2026-09-11T09:50:31.844Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-11","state_changed":true}]},"seller":{"wallet":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","page":"https://tollindex.com/seller/0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","endpoints":964,"hosts":78},"reports":0,"registry_record":{"cdp":[{"tags":["biotech-ma","licensing","business-development","deal-signal","big-pharma"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":300},{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"GatewayWalletBatched","version":"1","verifyingContract":"0x77777777dcc4d5a8b6e418fd04d8997ef11000ee"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":604900},{"asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BENrLoUbndxoNMUS5JXApGMtNykLjFXXixMtpDwDR9SP"},"payTo":"985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1","amount":"350000","scheme":"exact","network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","maxTimeoutSeconds":300},{"asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:137","maxTimeoutSeconds":300},{"asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:42161","maxTimeoutSeconds":300},{"asset":"0x79A02482A880bCe3F13E09da970dC34dB4cD24D1","extra":{"name":"USDC","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:480","maxTimeoutSeconds":300},{"asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:143","maxTimeoutSeconds":300},{"asset":"0x779ded0c9e1022225f8e0630b35a9b54be713736","extra":{"name":"USD₮0","version":"1"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:196","maxTimeoutSeconds":300},{"asset":"0xb88339CB7199b77E23DB6E890353E22632Ba630f","extra":{"name":"USDC","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000","scheme":"exact","network":"eip155:999","maxTimeoutSeconds":300},{"asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA"},"payTo":"62A253YPATFNJCPRKID3FKD77MYJFNTVRYRP4B4JWG36EGLPY7UXFWGI7I","amount":"350000","scheme":"exact","network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","maxTimeoutSeconds":300},{"asset":"XRP","extra":{"invoiceId":"E422BB7BCCBF42799CFF84C6DAF39F27","sourceTag":804681468},"payTo":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","amount":"350000","scheme":"exact","network":"xrpl:0","maxTimeoutSeconds":300},{"asset":"524C555344000000000000000000000000000000","extra":{"issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","invoiceId":"FFF919DB71444632B00BE1B2CCD273E3","sourceTag":804681468},"payTo":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","amount":"0.35","scheme":"exact","network":"xrpl:0","maxTimeoutSeconds":300},{"asset":"0x8d0D000Ee44948FC98c9B98A4FA4921476f08B0d","extra":{"name":"World Liberty Financial USD","version":"1","signerAddress":"0x34F7a661160780Ce1346e6D7B96D2bE244590899","assetTransferMethod":"eip3009"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"350000000000000000","scheme":"exact","network":"eip155:56","maxTimeoutSeconds":300}],"quality":{"lastCalledAt":"2026-08-20T14:01:57.673Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal","extensions":{"bazaar":{"info":{"input":{"type":"http","method":"GET","queryParams":{"lang":"en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)","stage":"phase2 | phase3 | both (default: both)","condition":"Disease area — e.g. \"Obesity\" | \"Cardiovascular\" | \"Oncology\" | \"Rare Neurological\" | \"Autoimmune\"","deal_type":"acquisition | licensing | both (default: both)"}},"output":{"type":"json","example":{"query_summary":{"as_of":"2026-06-07","stage":"both","condition":"Obesity","deal_type":"both"},"market_context":{"approved_leaders":["Semaglutide (Novo Nordisk — Wegovy)","Tirzepatide (Lilly — Zepbound)"],"big_pharma_strategic_need":"Roche, AstraZeneca, Pfizer, Amgen all need next-gen obesity assets. Roche acquired Carmot Therapeutics for $2.7B. AZ acquired Eccogene for obesity pipeline.","total_addressable_market_usd_bn":100},"recent_deal_comps":[{"deal":"Roche / Carmot Therapeutics","year":2023,"stage":"PHASE1/2","mechanism":"GLP-1 peptide","value_usd_bn":2.7},{"deal":"AstraZeneca / Eccogene","year":2024,"stage":"PHASE2","mechanism":"Small-molecule GLP-1","value_usd_bn":1.85},{"deal":"Amgen / ChemoCentryx","year":2022,"stage":"Approved","mechanism":"C5aR1","value_usd_bn":3.7}],"acquisition_targets":[{"asset":"Mazdutide (IBI362)","risks":["China geopolitical risk for IP transfer","Phase 3 US/EU data needed before deal close"],"stage":"PHASE3","company":"Innovent Biologics (China)","deal_comp":"Structure Day1 Biosciences (Pfizer) $1.25B + milestones — Phase 2 obesity asset. Mazdutide later-stage = premium.","mechanism":"GLP-1/glucagon dual agonist","probability":"High","clinical_data":"Phase 3 China data strong — 14.5% body weight reduction at 52 weeks","deal_rationale":"Ex-China rights available. Differentiated vs. semaglutide on muscle preservation. Lilly or Roche most likely acquirers.","estimated_deal_value_usd_m":"800-2000"}],"deal_timing_signals":"Obesity M&A is peak hot. Big pharma BD teams are actively searching — any Phase 2 readout with >10% weight loss and clean safety profile will attract inbound interest within 3-6 months of data release.","licensing_opportunities":[{"asset":"CT-388 (dual GLP-1/GIP)","notes":"Roche may sublicense ex-US rights to regional partners in Asia/LatAm","company":"Carmot Therapeutics (acq. Roche)","estimated_license_value_usd_m":"300-800"}]}}},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","properties":{"lang":{"type":"string"},"stage":{"type":"string"},"condition":{"type":"string"},"deal_type":{"type":"string"}}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}},"builder-code":{"info":{"a":"bc_gxy6qn5p"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"a":{"type":"string","pattern":"^[a-z0-9_]{1,32}$","description":"App builder code"},"s":{"type":"array","items":{"type":"string","pattern":"^[a-z0-9_]{1,32}$"},"description":"Service builder codes"},"w":{"type":"string","pattern":"^[a-z0-9_]{1,32}$","description":"Wallet builder code"}},"additionalProperties":false}}},"description":"Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.","lastUpdated":"2026-08-20T14:01:57.877Z","serviceName":"ClinicalIntelPulse","x402Version":2}],"binance":[{"type":"http","accepts":[{"asset":"0x8d0D000Ee44948FC98c9B98A4FA4921476f08B0d","payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"eip3009","network":"eip155:56","maxAmountRequired":"350000000000000000"}],"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal","description":"Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.","lastUpdated":1787408256222,"x402Version":2}]}}